{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:49:23Z","timestamp":1768682963397,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071634943","type":"print"},{"value":"9781071634950","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3495-0_14","type":"book-chapter","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T09:05:22Z","timestamp":1701248722000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liposome-Encapsulated Anti-inflammatory Proteins for Targeted Delivery to the Placenta to Treat Fetal Growth Restriction"],"prefix":"10.1007","author":[{"given":"Padma","family":"Murthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda K.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2019.00055","volume":"10","author":"A Malhotra","year":"2019","unstructured":"Malhotra A et al (2019) Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol (Lausanne) 10:55","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000113169","volume":"61","author":"KL Thornburg","year":"2008","unstructured":"Thornburg KL et al (2008) The role of growth in heart development. Nestle Nutr Workshop Ser Pediatr Program 61:39\u201351","journal-title":"Nestle Nutr Workshop Ser Pediatr Program"},{"issue":"2","key":"14_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","volume":"49","author":"DJ Barker","year":"2006","unstructured":"Barker DJ (2006) Adult consequences of fetal growth restriction. Clin Obstet Gynecol 49(2):270\u2013283","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"14_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajog.2010.10.915","volume":"204","author":"AA Baschat","year":"2011","unstructured":"Baschat AA, Odibo AO (2011) Timing of delivery in fetal growth restriction and childhood development: some uncertainties remain. Am J Obstet Gynecol 204(1):2\u20133","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"14_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0143-4004(05)80642-3","volume":"17","author":"L Macara","year":"1996","unstructured":"Macara L et al (1996) Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 17(1):37\u201348","journal-title":"Placenta"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12907-016-0023-y","volume":"16","author":"I Ptacek","year":"2016","unstructured":"Ptacek I et al (2016) Quantitative assessment of placental morphology may identify specific causes of stillbirth. BMC Clin Pathol 16:1","journal-title":"BMC Clin Pathol"},{"issue":"10","key":"14_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.placenta.2014.07.013","volume":"35","author":"TO Junaid","year":"2014","unstructured":"Junaid TO et al (2014) Fetoplacental vascular alterations associated with fetal growth restriction. Placenta 35(10):808\u2013815","journal-title":"Placenta"},{"issue":"5","key":"14_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1067\/mob.2002.122250","volume":"186","author":"R Levy","year":"2002","unstructured":"Levy R et al (2002) Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 186(5):1056\u20131061","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"14_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10495-010-0551-3","volume":"16","author":"AE Heazell","year":"2011","unstructured":"Heazell AE et al (2011) Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast. Apoptosis 16(2):135\u2013144","journal-title":"Apoptosis"},{"issue":"4","key":"14_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1203\/00006450-199710000-00016","volume":"42","author":"JD Glazier","year":"1997","unstructured":"Glazier JD et al (1997) Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res 42(4):514\u2013519","journal-title":"Pediatr Res"},{"issue":"12","key":"14_CR11","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1210\/jc.2002-020214","volume":"87","author":"M Johansson","year":"2002","unstructured":"Johansson M et al (2002) Activity and protein expression of the Na+\/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. J Clin Endocrinol Metab 87(12):5686\u20135694","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"14_CR12","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1038\/s41598-021-86268-1","volume":"11","author":"BC Baker","year":"2021","unstructured":"Baker BC et al (2021) Hypoxia and oxidative stress induce sterile placental inflammation in vitro. Sci Rep 11(1):7281","journal-title":"Sci Rep"},{"issue":"2","key":"14_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/molehr\/gax067","volume":"24","author":"M Lappas","year":"2018","unstructured":"Lappas M et al (2018) Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction. Mol Hum Reprod 24(2):94\u2013109","journal-title":"Mol Hum Reprod"},{"key":"14_CR14","doi-asserted-by":"crossref","unstructured":"Murthi P et al (2020) Decreased placental FPR2 in early pregnancies that later developed small-for-gestation age: a potential role of FPR2 in the regulation of epithelial-mesenchymal transition. Cells (4):9, 921","DOI":"10.3390\/cells9040921"},{"issue":"4","key":"14_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/ATVBAHA.119.312366","volume":"39","author":"IM Inocencio","year":"2019","unstructured":"Inocencio IM et al (2019) Effects of maternal sildenafil treatment on vascular function in growth-restricted fetal sheep. Arterioscler Thromb Vasc Biol 39(4):731\u2013740","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"14_CR16","doi-asserted-by":"publisher","first-page":"245 e241","DOI":"10.1016\/j.ajog.2016.02.040","volume":"215","author":"A Gonzalez-Candia","year":"2016","unstructured":"Gonzalez-Candia A et al (2016) Potential adverse effects of antenatal melatonin as a treatment for intrauterine growth restriction: findings in pregnant sheep. Am J Obstet Gynecol 215(2):245 e241\u2013245 e247","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"14_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3892\/etm.2017.4787","volume":"14","author":"X Kong","year":"2017","unstructured":"Kong X et al (2017) Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes. Exp Ther Med 14(3):2284\u20132290","journal-title":"Exp Ther Med"},{"issue":"17","key":"14_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.2217\/nnm-2016-0234","volume":"11","author":"LK Harris","year":"2016","unstructured":"Harris LK (2016) Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications? Nanomedicine (Lond) 11(17):2235\u20132238","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"14_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600349","volume":"2","author":"A King","year":"2016","unstructured":"King A et al (2016) Tumor-homing peptides as tools for targeted delivery of payloads to the placenta. Sci Adv 2(5):e1600349","journal-title":"Sci Adv"}],"container-title":["Methods in Molecular Biology","Trophoblasts"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3495-0_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T09:08:48Z","timestamp":1701248928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3495-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"ISBN":["9781071634943","9781071634950"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3495-0_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"30 November 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}